BEAT-AD trial gives established therapy a new twist
Strong epidemiologic findings are put to the test in ongoing clinical studies
Limited data makes it hard to avoid putting necks on the line
Higher isodose safe and efficient for 6 to 10 lesions
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
How and why MRI’s role in fetal neuroimaging has expanded
From a care path to boxing biomechanics and beyond
Trials examine low-intensity electricity’s effect on recurrent glioblastoma
Research sheds light on etiology for early injury after aneurysm rupture
Insights on post-concussion changes from acute to chronic stages
Exploring new uses of first approved therapy for PBA
Advertisement
Advertisement